Inventor · disambiguated record
Scott Braunstein
Also filed as: BRAUNSTEIN SCOTT
6 granted patents·2 pending applications·11 citations·filing 2022–2024
77Inventor score
Technology areasA61K
Top patents by PatentIndex Score
8 records- 0194US12115169B2Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersMARINUS PHARMACEUTICALS INC·Filed 2024·Granted Oct 15, 2024·3 cites·24 claims
- 0294US11980625B2Ganaxolone for use in treating tuberous sclerosis complexMARINUS PHARMACEUTICALS INC·Filed 2023·Granted May 14, 2024·4 cites·25 claims
- 0394US11701367B2Ganaxolone for use in treating tuberous sclerosis complexMARINUS PHARMACEUTICALS INC·Filed 2022·Granted Jul 18, 2023·4 cites·25 claims
- 0487US12268696B2Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersMARINUS PHARMACEUTICALS INC·Filed 2024·Granted Apr 8, 2025·0 cites·22 claims
- 0584US2025032512A1Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersMARINUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0683US12390477B2Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersIMMEDICA PHARMA US INC·Filed 2024·Granted Aug 19, 2025·0 cites·22 claims
- 0783US12383564B2Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersIMMEDICA PHARMA US INC·Filed 2024·Granted Aug 12, 2025·0 cites·22 claims
- 0877US2024374614A1Ganaxolone for use in treating tuberous sclerosis complexMARINUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Braunstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →